Markets:

Overview

News

Currencies

International

Treasuries

HEALTHCARE (NY:XLV)

147.79 +2.07 (+1.42%)

Streaming Delayed Price Updated: 11:04 AM EDT, May 19, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about HEALTHCARE

< Previous 1 2

...

22 23 24 25 26 27 28 29 30

...

42 43 Next >

Healthcare And Life Science Funds And ETFs Performance 2023-2024 ↗

February 05, 2024

Healthcare stocks usually provide a defensive posture to a stock portfolio.

Via Talk Markets

Topics ETFs

Markets suddenly price Eli Lilly stock for a breakout on earnings

February 05, 2024

The healthcare sector could see a sudden inflow of investment dollars, and Eli Lilly quickly becomes a favorite name in the space as markets and analysts bid up

Via MarketBeat

Topics Bonds Economy

US Stocks Rise At Week's Start, Tesla Rebounds, SoFi, Lucid Shine: What's Driving Markets Monday? ↗

January 29, 2024

Wall Street witnessed slight gains at midday on Monday, with investors eagerly awaiting a series of critical earnings reports, the Federal Reserve’s meeting on Wednesday and the much-anticipated job...

Via Benzinga

XLV Making Strong Reaction Higher From Extreme Area ↗

January 03, 2024

In this article, we will look at the past performance of the 4-hour Elliott Wave Charts of XLV

Via Talk Markets

Pfizer’s earnings growth trade at a deep discount, suddenly a buy

January 29, 2024

The healthcare sector is set to attract a new inflow of investment dollars, as seen in business activity and employment. Pfizer is the clear sector favorite

Via MarketBeat

Topics Economy

Just What Powers The SPY ↗

January 28, 2024

The S&P 500 closed the week below fresh highs thanks to a bout in tech and relative weakness in some semiconductors. The rally is broadening, though, with XLI and XLV appearing to be well-positioned.

Via Talk Markets

Topics Stocks

Stocks Ease Despite Benign Inflation Data, Bitcoin Stages Comeback: What's Driving Markets Friday? ↗

January 26, 2024

Stocks mixed in New York, with investors assessing mild inflation report and strong personal spending figures. Short-term Treasury yields rise, tech stocks lag, and Bitcoin surges 4.9%. Intel stock...

Via Benzinga

Topics Economy

5 top healthcare stocks for earnings growth in 2024

January 25, 2024

2024 holds promise for healthcare stocks, with Humana, Elevance, and others expected to boost earnings, as analysts say many industry pressures have been removed.

Via MarketBeat

Baby Bust: Will Falling Global Birth Rates Drive Markets Lower? ↗

January 22, 2024

In the U.S., the birth rate is still growing, but at a much slower rate since the global financial crisis in 2008.

Via Benzinga

Weekly Market Pulse: Is The Recession Finally Here? ↗

January 22, 2024

You need to sell when things look great – but not too soon – and buy when things look awful – but not too soon.

Via Talk Markets

Topics Economy

Pfizer, Autodesk, AbbVie And More: CNBC's 'Final Trades' ↗

January 19, 2024

On CNBC’s "Halftime Report Final Trades," Liz Young of BNY Mellon Investment Management named Health Care Select Sector SPDR Fund (NYSE: XLV)

Via Benzinga

Did Today's Volume Signal New Record Highs Ahead Of Sentiment ↗

January 18, 2024

An analysis of the major indexes' movement on higher than average volume.

Via Talk Markets

AI Drives Tech Rebound, Oil Soars, Bitcoin Tumbles: What's Driving Markets Thursday? ↗

January 18, 2024

During midday Thursday trading in New York, U.S. stocks displayed mixed performance, with the technology sector outperforming others as investors maintained a bullish outlook on artificial...

Via Benzinga

Topics Artificial Intelligence

Healthcare Sector Is Off To A Strong, Market-Leading Start In 2024 ↗

January 18, 2024

After a modest loss in 2023, shares in the healthcare sector are enjoying a market-leading rebound so far in the new year.

Via Talk Markets

US Stocks Sink, Tech And Real Estate Hit Hard Amid Rate Concerns, Dollar Surge: What's Driving Markets Wednesday? ↗

January 17, 2024

Another day of losses shook up Wednesday’s stock trading session on Wall Street. All major U.S. stock indices in the red, as investors expressed concerns that the Federal Reserve is not in a rush to...

Via Benzinga

Topics Economy

Are CVS store closures prescription for better financial health?

January 17, 2024

CVS plans to close dozens of Target pharmacies starting in February. Amid retail pharmacy challenges, CVS is shifting toward the managed-care industry.

Via MarketBeat

Topics Economy

UnitedHealth's rising premiums could cushion stubborn inflation

January 17, 2024

The healthcare sector is one of the prime suspects to attract safety-seeking investors in the coming market shift. Within it, THIS stock can prove a winner

Via MarketBeat

Topics Economy

2023 Year-End Sector Review – Part 2 ↗

January 13, 2024

In this 2023 year-end sector review, we will take a look at what kind of year it was for healthcare, industrial, technology, materials, REITs, and utility sectors. Additionally, how is 2024 shaping up...

Via Talk Markets

AstraZeneca: Rebound in 2024 with double-digit earnings growth

January 11, 2024

AstraZeneca's stock rose 8.95% in the past month on a bullish outlook, driven by growing sales of cancer and diabetes drugs and a strategic acquisition

Via MarketBeat

S&P 500's Projected EPS Growth In 2024: Why QQQ, QQQM Might Lead The Way ↗

January 10, 2024

The S&P 500 is poised to deliver double-digit growth to investors in 2024, fueled by 3 sectors. Even then, the Nasdaq-100 could outpace S&P 500. Here's why.

Via Benzinga

Topics Stocks

HCA Healthcare Rallies: Weight-loss drugs really a big threat?

January 08, 2024

HCA Healthcare rebounds amid concerns about weight-loss drugs' impact. The healthcare giant's revenue growth hints at resilience despite sector challenges.

Via MarketBeat

Topics ETFs

Are defensive sectors ready to outshine growth in 2024?

January 06, 2024

Is 2024 the year defensive stocks rotate into leadership? As the year gets underway, defensives such as healthcare, energy, utilities and consumer staples lead.

Via MarketBeat

Charted: S&P 500 Sector Performance In 2023 ↗

January 05, 2024

Information Technology, Communication Services, and Consumer Discretionary were the three biggest winners in 2023, all of them up more than 40% for the year.

Via Talk Markets

Topics Stocks

US Stocks Eye 3-Day Slump; Tech, Crypto Sell-Off Deepens, Oil, Dollar Rebound: What's Driving Markets Wednesday? ↗

January 03, 2024

The early 2024 sell-off is intensifying on Wall Street, with all major stock averages in the red on the second trading day of 2024.

Via Benzinga

Did Santa Claus Claus Leave Town A Day Early? ↗

January 02, 2024

With the exception of the Dow, stocks are down hard to begin the new calendar year.

Via Talk Markets

Topics Stocks

3 Biotech Stocks Set for Breakthroughs in 2024 ↗

January 02, 2024

With groundbreaking advancements in new medicine and science, 2024 holds a promising future for these biotech stocks.

Via InvestorPlace

Tech Drags On Wall Street As 2024 Kicks Off; Dollar and Treasury Yields Surge: What's Driving Markets Tuesday? ↗

January 02, 2024

Wall Street kicked off 2024 on a weaker note, with the S&P 500 dipping by 0.5%, and the Nasdaq 100 experiencing a 1.4% decline in midday trading in New York.

Via Benzinga

2023 Russell 1,000 Average Stock Performance By Sector ↗

January 02, 2024

2023 turned out to be a fantastic year for stocks after a horrible 2022.

Via Talk Markets

The Short-Term Uptrend May Be On Its Last Legs ↗

December 31, 2023

Believe it or not, the short-term uptrend looks set to continue, but it does appear to be on its last legs. It's time to prepare for a pullback in prices by having cash to deploy back into stocks when...

Via Talk Markets

Upward Trajectory For Biotech/Pharma M&A: Sector Trends Towards Pre-Pandemic Levels, Forecasts Positive For 2024 ↗

December 29, 2023

According to the Global Data report, the pharma sector in Q3 2023 witnessed deals worth $28 billion, down 28% from the $54 billion recorded in Q2 2023.

Via Benzinga

< Previous 1 2

...

22 23 24 25 26 27 28 29 30

...

42 43 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.